图书简介

Section 1: Why Commercial Determinants?; Chapter 1: Commercial Determinants of Health: An Introduction; Nason Maani, Mark Petticrew, and Sandro Galea; Chapter 2: A Systems Perspective on the Pathways of Influence between CDOH and Health; Cecile Knai and Natalie Savona; Chapter 3: Global Health and Equity Burden of Commercial Determinants of Health; Julia Anaf, Fran Baum, and Matt Fisher; Section 2: How Do Commercial Determinants Shape Upstream Drivers of Health?; Chapter 4: The Role of Policy in Studying the Commercial Determinants of Health; Benjamin Hawkins; Chapter 5: Understanding the Politics of the Commercial Determinants of Health; Eduardo J. Gomez; Chapter 6: The Role of Commercial Influences in Public Understanding of Harms, Causes and Solutions; Mark Petticrew, Nason Maani, and May van Schalkwyk; Chapter 7: The Role of Corporations in Influencing Culture; Nancy Tomes; Chapter 8: Industry Influence on Science: What Is Happening and What Can Be Done; Alice Fabbri and Anna Gilmore; Chapter 9: Role in Trade Deals and Investment; Pepita Barlow and Eric Crosbie; Section 3: Case Studies by Industry; Chapter 10: Hidden from View: Alcohol Industry Efforts to Keep the Epidemic of Alcohol-Related Harm from Public Awareness; Tim Stockwell and Erin Hobin; Chapter 11: Learning from 70 Years of Tobacco Control: Winning the War and Not Just the Battles; Anna B. Gilmore and Sarah Dance; Chapter 12: The Fossil Fuel Industry: Fuelling Doubt and Navigating Contradiction; May van Schalkwyk, Nason Maani, and Mark Petticrew; Chapter 13: The Gambling Industry: Harmful Products, Predatory Practices and the Politics of Knowledge; May van Schalkwyk and Rebecca Cassidy; Chapter 14: Sugar-Sweetened Beverages; Eric Crosbie, Laura Schmidt, Jim Krieger, and Marion Nestle; Section 4: Cross-Industry Mechanisms; Chapter 15: Marketing; Simone Pettigrew and Alexandra Jones; Chapter 16: Corporate Social Responsibility: Past, Present, and Future; Nino Paichadze, Vinu Ilakkuvan, Muluken Gizaw, and Adnan A. Hyder; Chapter 17: The Institutionalization of Corporate Power within Policy; Gary Fooks; Chapter 18: Corporations as Irresponsible Artificial People: Human Rights, Profits, and Public Health; George J. Annas; Chapter 19: Industry Influence on Research: A Cycle of Bias; Lisa Bero; Chapter 20: The Global Technology Sector as a Commercial Determinant of Health; Nora Kenworthy, Katerini Tagmatarchi Storeng, and Marco Zenone; Section 5: Advancing Science and Scholarship; Chapter 21: Defining the Commercial Determinants of Health; Jennifer Lacy-Nichols, Cassandra de Lacy-Vawdon, and Rob Moodie; Chapter 22: Assessing Power Structures; Joana Madureira Lima; Chapter 23: Rethinking Conflict of Interest: From Individual to Structural Understandings; Jeff Collin, Rob Ralston, and Sarah Hill; Chapter 24: Assessing the Health Impacts of the Commercial Determinants of Health; Luke N. Allen; Chapter 25: Assessing the Economic Impacts of Corporations; Martin McKee; Chapter 26: Prioritizing Research on the Foundational Drivers of Corporate Policy Influence; William H. Wiist; Chapter 27: The Influence of Commercial Industries on Public Discourse; Shona Hilton; Chapter 28: Commercial Determinants of Health in Low- and Middle-Income Countries; Salma M. Abdalla, Leona Ofei, Nason Maani, and Sandro Galea; Section 6: A Way Forward; Chapter 29: The Question of Industry Partnerships; Peter J. Adams; Chapter 30: Understanding and Managing Corporate Conflicts of Interest; Katherine Cullerton and Martin White; Chapter 31: Teaching the Commercial Determinants of Health; Nicholas Freudenberg and Eric Crosbie; Chapter 32: Learning from Experience: Identifying Key Intervention Points around Corporate Practices to Improve Health; Melissa Mialon, Julia Anaf, and Fran Baum; Chapter 33: A Policy Agenda for the Commercial Determinants of Health; Sally Casswell; Chapter 34: Commercial Determinants of Health: A Research and Translational Agenda; Nason Maani, Mark Petticrew, and Sandro Galea; ; Index $ MBNH; JPA; KCQ; KNXC $ Personal

Trade Policy 买家须知